No Data
March 24th [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 Mitachi Industries <3321> 1178 yen (3/21) a trading company for Semiconductors and Electronic Components. Considering recent performance trends, the Financial Estimates for the fiscal year ending May 2025 have been revised upwards. Operating profit is estimated at 2.1 billion yen (a 31.9% increase from the previous term). This is about a 10% increase from the previous estimate. The upward revision is due to the transfer of the commercial flow of automotive-related clients starting in the second quarter and solid orders in consumer-related EMS, etc. 【Emerging Markets Stocks】 Keipharma <489
The market is soft, with few clues, and profit-taking Sell may be dominant.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to exhibit a weak performance. Last weekend, on the 21st, in the U.S. stock market, the Dow Inc rose slightly by 32.03 points (+0.08%) to 41,985.35 dollars. The lackluster earnings outlook for sporting goods manufacturer Nike (NKE) and logistics company FedEx (FDX), along with notable technical selling due to stock index futures and Single Option settlements, stood out. In contrast, the rise of aircraft manufacturer Boeing (BA) supported the market.
Kei Pharma continues to be overweight: Preparing for corporate clinical trials for the FTD candidate drug 'KP2021' ETC.
Regarding K Pharma <4896.T>, the wealth advisor's report dated the 7th maintains the expected stock price range of 850-1050 yen and continues the investment rating as "Overweight" (Bullish). The company is a bio-venture originating from Keio University, engaged in both iPS drug development and regenerative medicine. The rights for the development pipeline related to ALS (amyotrophic lateral sclerosis) for the new drug candidate "KP2011" have been licensed to Alfresa Pharma in Japan, as noted in the report.
K Pharma: Financial results presentation materials for the fiscal year ending 2024/12
K Pharma: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
New Capital HD ETC [Stocks with attractive features based on changes in Volume]
Stock closing prices compared to the previous day Volume <6538> Disruptors 189,397,392,400 <2776> Shinto HD 161,101,772,580 <9165> Qualtech 130,368,422,200 <2437> Shinwa 297,523,314,900 <3803> Image Information 51,233,245,500 <2983> R Planner 142,417,450,680 <1622> Automobiles 291,003,753,749 <2962> Technisco 3,021.